64 related articles for article (PubMed ID: 17020979)
1. Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases.
Lessard L; Karakiewicz PI; Bellon-Gagnon P; Alam-Fahmy M; Ismail HA; Mes-Masson AM; Saad F
Clin Cancer Res; 2006 Oct; 12(19):5741-5. PubMed ID: 17020979
[TBL] [Abstract][Full Text] [Related]
2. Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity.
Pérez-Gómez JM; Montero-Hidalgo AJ; Fuentes-Fayos AC; Sarmento-Cabral A; Guzmán-Ruiz R; Malagón MM; Herrera-Martínez AD; Gahete MD; Luque RM
Rev Endocr Metab Disord; 2023 Dec; 24(6):1165-1187. PubMed ID: 37819510
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Properties of 4', 5, 7-Trihydroxyflavone (Apigenin) and Its Impact on Cell Signaling Pathways.
Abid R; Ghazanfar S; Farid A; Sulaman SM; Idrees M; Amen RA; Muzammal M; Shahzad MK; Mohamed MO; Khaled AA; Safir W; Ghori I; Elasbali AM; Alharbi B
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807549
[TBL] [Abstract][Full Text] [Related]
4. Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis.
Vlachostergios PJ; Karathanasis A; Papandreou CN; Tzortzis V
World J Oncol; 2021 Dec; 12(6):232-239. PubMed ID: 35059083
[TBL] [Abstract][Full Text] [Related]
5. Radioresistance in Prostate Cancer: Focus on the Interplay between NF-κB and SOD.
Kumar S; Clair DS
Antioxidants (Basel); 2021 Nov; 10(12):. PubMed ID: 34943029
[TBL] [Abstract][Full Text] [Related]
6. ISL1 promotes enzalutamide resistance in castration-resistant prostate cancer (CRPC) through epithelial to mesenchymal transition (EMT).
Choi JD; Kim TJ; Jeong BC; Jeon HG; Jeon SS; Kang MY; Yeom SY; Seo SI
Sci Rep; 2021 Nov; 11(1):21984. PubMed ID: 34753990
[TBL] [Abstract][Full Text] [Related]
7.
Seonu SY; Kim MJ; Yin J; Lee MW
Molecules; 2021 Jun; 26(13):. PubMed ID: 34201712
[No Abstract] [Full Text] [Related]
8. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
[TBL] [Abstract][Full Text] [Related]
9. Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence.
Zupancic M; Pospihalj B; Cerovic S; Gazic B; Drev P; Hocevar M; Perhavec A
Radiol Oncol; 2020 Apr; 54(2):194-200. PubMed ID: 32324163
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of cystathionine γ-lyase promotes prostate cancer progression and metastasis.
Wang YH; Huang JT; Chen WL; Wang RH; Kao MC; Pan YR; Chan SH; Tsai KW; Kung HJ; Lin KT; Wang LH
EMBO Rep; 2019 Oct; 20(10):e45986. PubMed ID: 31468690
[TBL] [Abstract][Full Text] [Related]
11. Low Tristetraprolin Expression Is Associated with Lethal Prostate Cancer.
Gerke T; Beltran H; Wang X; Lee GM; Sboner A; Karnes RJ; Klein EA; Davicioni E; Yousefi K; Ross AE; Börnigen D; Huttenhower C; Mucci LA; Trock BJ; Sweeney CJ
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):584-590. PubMed ID: 30420441
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of NF-κB heterodimer RelA/p50 in human urothelial carcinoma.
Durairajan S; Jebaraj Walter CE; Samuel MD; Palani D; G DJD; C GPD; Pasupati S; Johnson T
PeerJ; 2018; 6():e5563. PubMed ID: 30225173
[TBL] [Abstract][Full Text] [Related]
13. Suppressed epithelial-mesenchymal transition and cancer stem cell properties mediate the anti-cancer effects of ethyl pyruvate via regulation of the AKT/nuclear factor-κB pathway in prostate cancer cells.
Huang B; Lv DJ; Wang C; Shu FP; Gong ZC; Xie T; Yu YZ; Song XL; Xie JJ; Li S; Liu YM; Qi H; Zhao SC
Oncol Lett; 2018 Aug; 16(2):2271-2278. PubMed ID: 30008929
[TBL] [Abstract][Full Text] [Related]
14. Calcium and Nuclear Signaling in Prostate Cancer.
Maly IV; Hofmann WA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671777
[TBL] [Abstract][Full Text] [Related]
15. miR-30e* is overexpressed in prostate cancer and promotes NF-κB-mediated proliferation and tumor growth.
Egan SM; Karasik E; Ellis L; Gollnick SO
Oncotarget; 2017 Sep; 8(40):67626-67638. PubMed ID: 28978058
[TBL] [Abstract][Full Text] [Related]
16. microRNA-372 Suppresses Migration and Invasion by Targeting p65 in Human Prostate Cancer Cells.
Kong X; Qian X; Duan L; Liu H; Zhu Y; Qi J
DNA Cell Biol; 2016 Dec; 35(12):828-835. PubMed ID: 27673408
[TBL] [Abstract][Full Text] [Related]
17. Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk.
Averett C; Bhardwaj A; Arora S; Srivastava SK; Khan MA; Ahmad A; Singh S; Carter JE; Khushman M; Singh AP
Carcinogenesis; 2016 Nov; 37(11):1052-1061. PubMed ID: 27609457
[TBL] [Abstract][Full Text] [Related]
18. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression.
Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM
Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074
[TBL] [Abstract][Full Text] [Related]
19. Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
Shukla S; Shankar E; Fu P; MacLennan GT; Gupta S
PLoS One; 2015; 10(9):e0138710. PubMed ID: 26379052
[TBL] [Abstract][Full Text] [Related]
20. Potential Cross-Talk between Alternative and Classical NF-κB Pathways in Prostate Cancer Tissues as Measured by a Multi-Staining Immunofluorescence Co-Localization Assay.
Labouba I; Le Page C; Communal L; Kristessen T; You X; Péant B; Barrès V; Gannon PO; Mes-Masson AM; Saad F
PLoS One; 2015; 10(7):e0131024. PubMed ID: 26186215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
